PCOS Treatment Market to Witness Significant Growth until 2025
Rising obesity among women
population to drive the growth of global PCOS treatment market
According
to TechSci Research report, “Global PCOS
Treatment Market By Surgery (Ovarian Wedge Resection, Cyst Aspiration,
Laparoscopic Ovarian Drilling), By Drug (Ovulation Inducing Agents,
Insulin-Sensitizing Agents, Oral Contraceptives, Antiandrogens,
Anti-Depressants, Insulin-Sensitizing Agents, Anti-Obesity Drugs, Others), By
Diagnosis (Pelvic Examination, Ultrasound, Blood Tests), By End User (Hospitals
& Clinics, Ambulatory Surgical Centers, Fertility Clinics), By Region,
Forecast & Opportunities, 2025”, the global PCOS treatment market is expected to grow at a formidable
rate of around 8.63% during the forecast period on account of the rising
awareness pertaining to diseases and reproductive health among the population.
Additionally, initiatives taken by various government and non-government
organizations for spreading awareness and providing schemes and services for
the welfare of women is further expected to positively impact the growth of
market over the next few years. Furthermore, easy access to PCOS therapeutics,
growing demand for PCOS medication and rising popularity of combination therapy
are further expected to foster the growth of market through 2025. However, easy
availability of generics and off the label drugs might hinder the growth of
market during forecast period. Additionally, lack of approved therapeutics and
side effects of the available drugs might hamper the growth of market over the
next few years. Also, at present no targeted therapy is available for this
syndrome & it is only controlled through medication and some surgical
procedures.
Browse
1 market data Tables and 37 Figures
spread through 110 Pages and an in-depth TOC
on
" Global PCOS Treatment Market"
https://www.techsciresearch.com/report/pcos-treatment-market/4683.html
The global PCOS treatment market is segmented based on surgery, drug,
diagnosis, end user, company and region. The drug the market can be categorized
into ovulation inducing agents, oral contraceptives, antiandrogens,
anti-depressants, insulin-sensitizing agents, anti-obesity drugs, others. The oral
contraceptive drugs are expected to register the fastest growth through the
forecast period owing to their widespread use as first line of treatment for
PCOS. These contraceptives help in regulating the menstruation cycles in the
patient. Additionally, these are helpful in treating severe menstrual pain,
Premenstrual syndrome (PMS), and acne, which are common symptoms of Polycystic
ovary syndrome.
Bristol-Myers Squibb Company, Bayer
AG, Pfizer, Inc., Abbott Laboratories, Inc., Merck & Co., Inc., Sanofi SA, AstraZeneca
Plc, Novartis AG, Teva Pharmaceutical Industries Limited, Ferring
Pharmaceuticals, Inc., and others are some of the leading players operating
in global PCOS treatment market. The companies operating in the market are
using organic strategies such as product launches, mergers and collaborations
to boost their share. For instance, in January 2106, AstraZeneca announced that
they have started start up for women health treatment and invested USD 62 million
in drug development for poly cystic ovarian disorder.
Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=4683
Customers can also request for 10% free customization on this report.
“North
America is expected to dominate
the global PCOS treatment market during the forecast period, owing to the presence
of well-developed healthcare infrastructure in the region. Additionally, availability
of skilled medical personnel coupled with large PCOS patient pool especially in
the United States is further expected to create lucrative opportunities for the
market players over the next few years.” said Mr. Karan
Chechi, Research Director with TechSci Research, a research based global
management consulting firm.
“Global PCOS Treatment Market By Surgery (Ovarian
Wedge Resection, Cyst Aspiration, Laparoscopic Ovarian Drilling), By Drug
(Ovulation Inducing Agents, Insulin-Sensitizing Agents, Oral Contraceptives,
Antiandrogens, Anti-Depressants, Insulin-Sensitizing Agents, Anti-Obesity
Drugs, Others), By Diagnosis (Pelvic Examination, Ultrasound, Blood Tests), By
End User (Hospitals & Clinics, Ambulatory Surgical Centers, Fertility
Clinics), By Region, Forecast & Opportunities, 2025”,” has evaluated the future growth potential of global PCOS
treatment market and provides statistics & information on market size,
structure and future market growth. The report intends to provide cutting-edge
market intelligence and help decision makers take sound investment decisions. Besides,
the report also identifies and analyzes the emerging trends along with
essential drivers, challenges and opportunities in global PCOS treatment market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]